University of Maryland School of Medicine Center for Vaccine Development CRS Trials

University of Maryland School of Medicine Center for Vaccine Development CRS	Welcome, Profile Billing Logout

University of Maryland School of Medicine Center for Vaccine Development CRS

Welcome, Profile Billing Logout

2 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Haney, Connie

NCT03916185: Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age

Completed

1/2

RSV ΔNS2/Δ1313/I1314L Vaccine, RSV 6120/ΔNS2/1030s Vaccine, RSV 276 Vaccine, Placebo

National Institute of Allergy and Infectious Diseases (NIAID)

Respiratory Syncytial Virus (RSV)

01/24

04/24

Wadsworth, Linda